BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27454599)

  • 1. Demonstration of Response to Androgen Deprivation Therapy by 68Ga-PSMA PET/CT.
    Soydal C; Ozkan E; Kaya B; Kucuk ON
    Clin Nucl Med; 2016 Oct; 41(10):794-6. PubMed ID: 27454599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Utility of 68Ga-PSMA PET/CT in Poorly Differentiated Metastatic Prostate Cancer.
    Demirkol MO; Kiremit MC; Acar O; Ucar B; Saglican Y
    Clin Nucl Med; 2017 May; 42(5):403-405. PubMed ID: 28319496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of androgen deprivation therapy on
    Onal C; Guler OC; Torun N; Reyhan M; Yapar AF
    Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):632-641. PubMed ID: 31732768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can
    Chen M; Zhuang J; Fu Y; Guo S; Zang S; Ai S; Qiu X; Wang F; Guo H
    J Urol; 2021 Apr; 205(4):1082-1089. PubMed ID: 33207140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 68Ga-PSMA Uptake by Dermatofibroma in a Patient With Prostate Cancer.
    Aydin F; Akçal A; Ünal B; Sezgin Göksu S; Güngör F
    Clin Nucl Med; 2017 May; 42(5):358-360. PubMed ID: 28240656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Imaging in Neuroendocrine Differentiation of Prostate Cancer: 68Ga-PSMA Versus 68Ga-DOTA NOC PET-CT.
    Usmani S; Ahmed N; Marafi F; Rasheed R; Amanguno HG; Al Kandari F
    Clin Nucl Med; 2017 May; 42(5):410-413. PubMed ID: 28240661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epididymal Metastasis of Prostate Cancer Detected With 68Ga-PSMA-PET/CT.
    Serfling S; Luther A; Kosmala A; Bluemel C
    Clin Nucl Med; 2016 Oct; 41(10):792-3. PubMed ID: 27355849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG, 68Ga-DOTATATE and 68Ga-PSMA Positive Metastatic Large Cell Neuroendocrine Prostate Tumor.
    Acar E; Kaya GÇ
    Clin Nucl Med; 2019 Jan; 44(1):53-54. PubMed ID: 30325820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing PSMA-uptake with androgen deprivation therapy - a new way to detect prostate cancer metastases?
    Leitsmann C; Thelen P; Schmid M; Meller J; Sahlmann CO; Meller B; Trojan L; Strauss A
    Int Braz J Urol; 2019; 45(3):459-467. PubMed ID: 30901173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subacute Cortical Infarct Showing Uptake on 68Ga-PSMA PET/CT.
    Chan M; Hsiao E
    Clin Nucl Med; 2017 Feb; 42(2):110-111. PubMed ID: 27997426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection Efficacy of Hybrid
    Einspieler I; Rauscher I; Düwel C; Krönke M; Rischpler C; Habl G; Dewes S; Ott A; Wester HJ; Schwaiger M; Maurer T; Eiber M
    J Nucl Med; 2017 Jul; 58(7):1081-1087. PubMed ID: 28209912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 68Ga-DOTATOC and 68Ga-PSMA PET/CT Unmasked a Case of Prostate Cancer With Neuroendocrine Differentiation.
    Chen S; Cheung SK; Wong KN; Wong KK; Ho CL
    Clin Nucl Med; 2016 Dec; 41(12):959-960. PubMed ID: 27764046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenocarcinoma Prostate With Neuroendocrine Differentiation: Potential Utility of 18F-FDG PET/CT and 68Ga-DOTANOC PET/CT Over 68Ga-PSMA PET/CT.
    Parida GK; Tripathy S; Datta Gupta S; Singhal A; Kumar R; Bal C; Shamim SA
    Clin Nucl Med; 2018 Apr; 43(4):248-249. PubMed ID: 29474196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiphasic
    Beheshti M; Manafi-Farid R; Geinitz H; Vali R; Loidl W; Mottaghy FM; Langsteger W
    J Nucl Med; 2020 Oct; 61(10):1484-1490. PubMed ID: 32060214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary Opacities and Bronchiectasis Avid on 68Ga-PSMA PET.
    Bouchelouche K; Vendelbo MH
    Clin Nucl Med; 2017 Apr; 42(4):e216-e217. PubMed ID: 28134694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer.
    Afshar-Oromieh A; Debus N; Uhrig M; Hope TA; Evans MJ; Holland-Letz T; Giesel FL; Kopka K; Hadaschik B; Kratochwil C; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2045-2054. PubMed ID: 29980832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidental Detection of Head and Neck Squamous Cell Carcinoma on 68Ga-PSMA-11 PET/CT.
    Lawhn-Heath C; Flavell RR; Glastonbury C; Hope TA; Behr SC
    Clin Nucl Med; 2017 Apr; 42(4):e218-e220. PubMed ID: 28166149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intertumoral Heterogeneity of 18F-FDG and 68Ga-PSMA Uptake in Prostate Cancer Pulmonary Metastases.
    Perez PM; Hope TA; Behr SC; van Zante A; Small EJ; Flavell RR
    Clin Nucl Med; 2019 Jan; 44(1):e28-e32. PubMed ID: 30394930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection rate of PET/CT in patients with biochemical relapse of prostate cancer using [
    Berliner C; Tienken M; Frenzel T; Kobayashi Y; Helberg A; Kirchner U; Klutmann S; Beyersdorff D; Budäus L; Wester HJ; Mester J; Bannas P
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):670-677. PubMed ID: 27896369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal Stromal Tumor Showing Intense Tracer Uptake on PSMA PET/CT.
    Noto B; Weckesser M; Buerke B; Pixberg M; Avramovic N
    Clin Nucl Med; 2017 Mar; 42(3):200-202. PubMed ID: 28072616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.